Letter: Effective funding of medical research
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Sir: Further discussion about the role of charities in funding medical research is to be welcomed. But the fact that the largest and most well-known charities are concerned with diseases such as cancer or heart disease does not mean that there is no important charitable research funding of other diseases, for example, Aids.
There are many smaller charities, such as Avert (the Aids Education & Research Trust), which has for the past six years been funding research into Aids. Smaller research charities often have difficulty raising funds because they cannot get publicity for their work.
They do not have the promotional and advertising budgets of the larger charities, and in certain areas such as Aids may have great difficulty in getting people to support their work publicly.
But the value of a charity's work should not be judged just by its size and the number of projects it funds. The type of project that is funded is often just as important. Charities, particularly the smaller ones, can often be more flexible in their approach, and can fund the innovative and exciting projects that may well be turned down by government bodies, and which may not be financially attractive enough to be funded by a pharmaceutical company.
If medical research in the UK is going to continue to be successful, we need increased funding not only from the government, but also from charities and industry.
Yours faithfully,
ANNABEL KANABUS
Trustee, Aids Education
& Research Trust
Horsham,
West Sussex
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments